… and careful monitoring may be required in patients with severe hepatic impairment.
Elderly patients
In the elderly increase of the dosage should take place with care (see sections 4.2 and 5.2).
Patients with renal impairment
Amlodipine may be used in such patients at normal doses. Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment. Amlodipine is not dialysable.
Ingredients …
Identical in all 8 labels. Surrounding text shown from Zydus Pharmaceuticals UK Ltd.
… tration and careful monitoring may be required in patients with severe hepatic impairment.
Elderly:
In the elderly increase of the dosage should take place with care (see sections 4.2 and 5.2).
Renal impairment:
Amlodipine may be used in such patients at normal doses. Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment. Amlodipine is not dialyzable.
Amlodipine c …
Identical in all 3 labels. Surrounding text shown from Sandoz Limited.
… areful monitoring may be required in patients with severe hepatic impairment.
Elderly patients:
In the elderly increase of the dosage should take place with care (see sections 4.2 and 5.2).
Patients with renal impairment:
Amlodipine may be used in such patients at normal doses. Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment. Amlodipine is not dialysable.
Sodium
This …
… l monitoring may be required in patients with severe hepatic impairment.
Use in elderly patients
In the elderly increase of the dosage should take place with care (see sections 4.2 and 5.2).
Use in renal failure
Amlodipine may be used in such patients at normal doses. Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment. Amlodipine is not dialysable.
Administrat …